Argininosuccinate lyase: purification and characterization from human liver

Area of Science:

• Biochemistry
• Enzymology

Background:

• Argininosuccinate lyase (ASL) is a key enzyme in the urea cycle, essential for ammonia detoxification.
• Understanding ASL's properties is vital for metabolic research and potential therapeutic interventions.

Purpose of the Study:

• To purify and characterize argininosuccinate lyase from human liver.
• To determine the enzyme's kinetic properties, molecular structure, and immunological specificity.

Main Methods:

• Enzyme purification to near homogeneity.
• Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) for molecular weight determination.
• Sedimentation equilibrium centrifugation for quaternary structure analysis.
• Kinetic assays (Km values) and inhibition studies.
• Antibody production and immunoadsorption assays for specificity.

Main Results:

• Purified human liver ASL exhibited specific activities of 10.3 and 8.0 µmol/min/mg in forward and reverse reactions, respectively.
• SDS-PAGE indicated a minimum subunit molecular weight of 49,000 Da; sedimentation equilibrium revealed a tetrameric structure (187,000 Da).
• Kinetic analysis showed Km values of 0.20 mM (argininosuccinate), 5.3 mM (fumarate), and 3.0 mM (arginine); GTP had no effect.
• Generated antibodies were specific to human ASL, showing minimal cross-reactivity with beef liver ASL and none with rat liver ASL, and recognized the enzyme in both liver extracts and skin fibroblasts.

Conclusions:

• Human liver argininosuccinate lyase is a tetrameric protein with distinct kinetic parameters.
• The enzyme's structure and properties are similar to its beef liver counterpart, but immunological studies highlight species-specific epitopes.
• The developed antibodies are specific tools for studying human ASL in various biological contexts.